July 22, 2024 – Patient Worthy

https://unsplash.com/photos/In4XVKhYaiI

Long-Term Safety and Efficacy Data Available on Vabysmo for Diabetic Macular Edema

Post author:Jessica Lynn
Post published:July 22, 2024
Post category:Diabetic retinopathy

Since its development and approval, Vabysmo has been a game-changer in the ophthalmologic space. The injectable VEGF and Ang-2 inhibitor treats diabetic macular edema (DME), macular edema with retinal vein…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More